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Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens [1] [2] [3] . Aromatase inhibitors therefore constitute a frontline therapy for oestrogen-dependent breast cancer 3, 4 . In a threestep process, each step requiring 1 mol of O 2 , 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16a-hydroxytestosterone to oestrone, 17b-oestradiol and 17b,16a-oestriol, respectively [1] [2] [3] . The first two steps are C19-methyl hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.
Human aromatase is the product of the CYP19A1 gene on chromosome 15q21.1 and consists of a haem group and a polypeptide chain of 503 amino-acid residues. Although aromatase has been extensively studied for more than 35 years 1-3,5-19 , the mechanism of the aromatization step remains poorly understood. Many soluble bacterial P450s, such as P450cam 20 and P450eryF
21
, as well as recombinant human microsomal P450s, such as 3A4 (ref. 22) , 2D6 (ref. 23) and 2A6 (ref. 24) , that metabolize drug/xenobiotics, have been crystallized and studied by X-ray crystallography. Several laboratories have reported the purification of aromatase from human placenta 7, 8 and recombinant expression systems 14, 18 . Nevertheless, attempts to crystallize either the placental or a recombinant or modified aromatase have been unsuccessful and an experimental aromatase structure has remained unknown. Numerous mechanistic and homology models based on known P450 structures and site-directed mutagenesis data have been proposed 5, 6, [9] [10] [11] [12] [13] [15] [16] [17] [18] , leading to the identification of catalytically important residues and possible substrate-binding modes.
The 2.90-Å resolution crystal structure of aromatase purified from term human placenta 19 in complex with its natural substrate androstenedione (androst-4-ene-3,17-dione) exhibits the characteristic cytochrome P450 fold ( Fig. 1a ; see Methods, Supplementary Fig. 1 and Supplementary Table 1 ). Androstenedione binds with its b-face oriented towards the haem group and C19 4.0 Å from the Fe atom ( Fig. 1b and Supplementary Fig. 2 ). To test the catalytic viability of the substrate-binding mode, the haem Fe is modelled as a hypothetical oxyferryl Fe(IV)5O moiety (Fig. 1c) . The resulting binding geometry of the C19 methyl hydrogens closely resembles that of the reactants for hydroxylation by P450cam (Fig. 1b) . The 17-keto oxygen of the substrate makes a hydrogen bond (2.8 Å ) with the backbone amide of Met 374 and a weak contact (3.4 Å ) with NH1 of Arg 115 (Fig. 1b) . The 3-keto oxygen is 2.6 Å from the carboxylate O d2 of the Asp 309 side chain (Figs 1b and 2a, b) , indicating that the carboxylate moiety may be protonated. The hydrophobic residues and porphyrin rings of haem pack tightly against the steroid backbone, forming a cavity complementary in shape to the bound steroid (Fig. 2a) A distortion in the I-helix backbone resulting in a roughly 3.5-Å displacement of the helix axis is crucial for creating the androgenspecific binding pocket at the active site. This shift in the helix axis caused by Pro 308, a residue unique to aromatase among all P450s, is stabilized by a strong Ala 306CO???HOThr 310 (2.8 Å ) hydrogen bond, as well as by an Asp 309 peptide CO???water (3.4 Å ) interaction (Fig. 2b) . Although an irregularity in the I-helix backbone at this region is observed in other P450s [20] [21] [22] [23] [24] 26 , this Pro 308-mediated axis shift precisely accommodates the 3-keto end of androstenedione near the fifth turn of the helix (Met 303 to Ala 307), allowing the Asp 309 side chain to hydrogen-bond to the 3-keto oxygen (Fig. 2b) . Superposition of the aromatase backbone with bacterial P450cam and P450eryF (Supplementary Fig. 3 ) as well as with human P450 3A4 and P450 2D6 ( Supplementary Fig. 4) shows that without this shift, the 3-keto end of the substrate would clash with the I-helices of P450cam, P450eryF, P450 2D6 and P450 3A4. The structure therefore confirms the critical roles of Pro 308 and Asp 309 predicted by mutagenesis and modelling 9, 10, 15 . The Asp 309 side chain also forms a hydrogen bond with a water molecule 3.0 Å from O d1 (Figs 1b and 2a and Supplementary Fig. 5 ). The geometries of these two hydrogen bonds place the 3-keto oxygen and the water oxygen atom roughly in the carboxylate plane (Fig. 2b) . Furthermore, this water molecule is situated at 3.6 Å from the guanidinium group of the Arg 192 side chain (Fig. 2b) , which forms a salt bridge with Glu 483. An elongated electron density adjacent to the Ser 478 side chain ( Supplementary Fig. 5 ) was modelled as two water molecules, hydrogen-bonded to each other and to the Ser 478 side chain OH, which in turn donates a hydrogen bond to His 480 N d1 farther from the active site. The Ser 478 side chain is linked through these two water molecules to Arg 192 by a weak hydrogen bond (3.4 Å ; Fig. 2b and Supplementary Fig. 5 ). It is probably as a result of being linked to this network of proton donors on one side, and the keto group of a large hydrophobic substrate on the other, that the Asp 309 side chain remains protonated and engaged in the substratebinding interaction. This network could also serve as the proton source for the proposed participation of the Asp 309 carboxylate moiety in the enolization process, as discussed below.
H2b of the A-ring of the bound androstenedione ( Fig. 3a ) that gets abstracted in the aromatization step is close to the Ala 306CO???HOcThr 310 pair (C5O???H2b-C2: 3.7 Å and C2-H2b???OcH: 3.8 Å ). Thr 310, highly conserved in P450s, has been implicated in the P450 hydroxylation steps. The mechanism of P450 hydroxylation has been studied extensively for two bacterial enzymes, P450cam 20 and P450eryF 21 . In the dioxygen complex of P450cam, the residue pair Thr 252-Gly 248 carbonyl, and two catalytic water molecules, are involved in the activation of ferrous dioxygen to the hydroxylating Fe(IV)5O species by providing two protons 20 . A similar hydroxylation mechanism involving the corresponding Thr 310-Ala 306 carbonyl pair, and catalytic water molecules (the binding of which could be promoted by dioxygen binding as in P450cam), is probably at work for each of the first two steps catalysed by aromatase, yielding the C19-aldehyde derivative of androstenedione through 19,19-gem-diol formation and retention of the pro-S hydrogen 1-3,5,6 . The same catalytic residues could also be responsible for the H2b abstraction of the 2,3-enolization processes in the aromatization step. To accomplish this, a nucleophilic attack on H2b-C by the Ala 306CO???HOcThr 310 moiety (perhaps along with a water) and a concerted electrophilic attack on the C3-keto oxygen by a protonated Asp 309 side chain could promote the H2b abstraction and 2,3-enolization, akin to -H 2 C2-C3-keto to -HC25C3-enol tautomerization (Fig. 3b) . A bound water molecule (perhaps linked to the proton relay network) between Thr 310-Oc and the ironperoxy/hydroperoxy intermediate could lower the pK a of Thr 310-OcH, rendering Ala 306C5O a more potent nucleophile; alternatively, it could itself act as a nucleophile, as shown in Fig. 3b . Asp 309 thus seems to have a direct participation in enolization, unlike the indirect roles of Asp 251 and Glu 244 in hydroxylation by P450cam and P450eryF, respectively 20, 21 . A density-functiontheory calculation for the final catalytic step of aromatase suggests a strikingly low energy barrier (less than 7 kcal mol 21 ) for H1b abstraction when steroids are 2,3-enolized 27 . However, the 1b hydrogen is too far from this carbonyl (6.2 Å ) to be abstracted in such a manner. It points at and is close to the haem Fe (4.2 Å ), and is probably removed after the Fe-peroxy nucleophilic attack on the 19-aldehyde (Fig. 3b) as previously proposed 3,5,6 . To examine how a mechanism-based steroidal inhibitor could interfere with the aromatization process, an exemestane (Aromasin; one of the three aromatase inhibitors approved by the US Food and Drug Administration) molecule was built into the active site (Fig. 3c ) by using the androstenedione backbone. The two steroids superimpose quite well (root mean square (r.m.s.) deviation about 0.2 Å ), except for differences in puckering of the A-rings. The extra C6-methylidene group in exemestane is accommodated in a shallow hydrophobic crevice surrounded by the side-chain C atoms Thr 310-Cc, Val 370-Cc2 and Ser 478-Cb, at the mouth of the active-site access channel (described below). The distance between the methylidene C and Cc-Thr 310 is 3 Å , shorter than the van der Waals contact distance. Indeed, a slight adjustment of these side chains on the binding of exemestane is highly likely. The clamping of C6-methylidene in a hydrophobic surrounding, resulting in entropic gain and a lowering of the free energy and the dissociation constant, could greatly reduce the mobility of the Thr 310 side chain and/ or interfere with its ability to interact with the catalytic waters for the creation of the active oxyferryl moiety. Exemestane would thus remain tightly bound in the pocket without being hydroxylated at C19.
An access channel links the active site to the outer surface. Figure 4a is a view of the interior of a semi-transparent solvent-excluded surface 28 that also excludes the active-site region, consisting of the steroid-binding pocket and haem, from the protein interior by forming a 'pouch'-like cleft that opens only to the exterior through the channel, at the arrowhead. The inset shows a view along this channel, revealing the locations of three water molecules within the channel and a glimpse of the opening to the active-site cavity. The salt-bridging Arg 192-Glu 483 pair as well as Asp 309 and Ser 478 line the channel that hosts the putative proton relay network and is also probably the major transport route to and from the active site for water, oxygen and steroid molecules. This channel seems to be a confluence of what was previously described as channels 2a, 2ac and 2c for other P450s 29 . Although it becomes narrower at points, the channel is probably flexible to permit the passage of molecules such as steroids.
Having seven cysteines in the reduced form, the bulk of aromatase probably resides in the reducing environment of the cytoplasm. A hydrophobicity plot of the aromatase sequence suggests lipid integration for residues 21-42 and 49-71, thereby placing the N terminus with glycosylation at Asn 12 on the opposite side; that is, the lumen 30 . It is possible that the transmembrane segment of residues 21-42, which is too short to traverse the bilayer as a regular a-helix, is at least partly an extended polypeptide devoid of secondary structure. This is consistent with the observed weak electron density for the polypeptide chain beyond residue 45 towards the N terminus. It is also likely that the hydrophobic helix A9 (residues 57-68) and part of helix A (residues 69-80) are embedded in the membrane. This arrangement positions several arginine (Arg 64, Arg 79 and Arg 86) and tryptophan (Trp 67 and Trp 88; Trp 239 from the F-G loop) residues at the lipid/protein interface, a telltale sign of lipid integration. Besides, electron densities for at least two detergent molecules were identified near Trp 67 of helix A9. We therefore propose that lipid integration of aromatase begins with these helices as the N terminus traverses farther into the bilayer towards the lumen side. A model (Fig. 4b ) based on these concepts places the entrance to the active-site access channel (Fig. 4a) on the membrane surface. Although other possible entry and exit routes cannot be excluded, this arrangement allows the lipophilic substrate to enter the aromatase active site directly from within the membrane, travelling between and across the F-G loop and the b8-b9 loop, roughly along the path indicated by the white arrow in Fig. 4b . The structure of aromatase therefore provides a rationale for its crucial membrane integration.
The crystal structure of human aromatase reveals a finely tuned molecular machine that makes oestrogens from androgens. Use of the molecular basis for enzyme-substrate and enzyme-drug interactions could lead to more efficacious intervention of oestrogen production.
METHODS SUMMARY
Aromatase was purified from term human placenta by immuno-affinity chromatography in a highly active form. It was complexed with androstenedione and crystallized at 4 uC in the oxidized high-spin ferric state of the haem iron with poly(ethylene glycol) 4000 as the precipitant. The space group was P3 2 21 and the unit cell parameters are a 5 b 5 140.2 Å , c 5 119.3 Å , a 5 b 5 90u, c 5 120u, having one aromatase molecule in the asymmetric unit. Diffraction data at about 100 K were collected initially at the Cornell High Energy Synchrotron Source (CHESS) and then to 2.90 Å resolution at the Advanced Photon Source, Argonne National Laboratory, with glycerol as a cryoprotectant. Two data sets at the Fe absorption edge were also collected at the CHESS. The structure was solved by the molecular replacement method coupled with Bijvoet difference Fourier synthesis for identifying the correct solution. Model building and refinement were performed with Coot and Refmac5, respectively. The final model contained 452 amino acid residues; 44 N-terminal and 7 C-terminal residues could not be built because of weakness of their electron densities. The final R factor for all reflections between 38 and 2.90 Å resolution was 0.214, and the R-free value was 0.244. The r.m.s. deviations of bond lengths and angles from ideal values were 0.009 Å and 1.32u, respectively. The average isotropic thermal factor for all atoms was 77.3 Å 2 . There were only two violations in the backbone torsion angle Ramachandran plot, both in the loop regions. The oxyferryl Fe(IV)5O moiety was generated by adding an oxygen atom to Fe with the modelling software MOE (Chemical Computing Group) The exemestane molecule was built into the active site by superimposing it on the experimentally derived androstenedione atomic positions with MOE.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. bilayer. a, The solvent-excluded surface 28 of aromatase excludes the steroidbinding pocket and haem from the protein interior by forming a 'pouch'-like cleft that has the only opening to the protein exterior through a channel, roughly at the arrowhead. The course of the polypeptide chain is shown in rainbow colour. Residues Arg 192, Asp 309, Ser 478 and Glu 483 border this channel from the protein interior; three water molecules, part of the proton relay network, are within the channel. The inset is a view along this channel at the arrowhead, showing the locations of water molecules and opening to the active site. b, In a proposed membrane integration model, the opening to the active-site access channel rests on the lipid bilayer surface, allowing the steroids to enter the aromatase active site directly from within the bilayer, roughly along the arrow shown. The model suggests lipid integration/ association of the N terminus up to helix A, and other loops near the C terminus. The orientation of aromatase is roughly the same in both panels.
METHODS
Purification and crystallization. The enzyme was purified to homogeneity from the microsomal fraction of homogenized fresh human placenta by immunoaffinity chromatography (Supplementary Fig. 1a ). The purified enzyme was highly active: the specific activity with androstenedione as the substrate ranged between about 10 and about 100 nmol min 21 mg 21 over a large number of purification experiments. Details of this procedure have been described previously 19, 31 . The absorption spectrum of the androstenedione complex had a Soret band at 394 nm ( Supplementary Fig. 1b) , which is characteristic of the oxidized highspin ferric (Fe 31 ) state of the haem iron and is suggestive of the formation of the androstenedione complex 32 . Freshly purified aromatase in 100 mM potassium phosphate buffer pH 7.4 containing 20% glycerol, 20 mM dithiothreitol, 0.1 mM androstenedione and 1 mM n-dodecyl-b-D-maltopyranoside (BDM) was mixed with reservoir cocktails of 24-30% poly(ethylene glycol) 4000 and 0.5 M NaCl in 0.05 M Tris-HCl buffer pH 8.5 and vapour-diffused in sealed 24-well sittingdrop plates against corresponding reservoir solution. The purification and crystallization experiments were all conducted at 4 uC. Reddish-brown hexagonal rod-shaped crystals appeared in 7-10 days and continued to grow up to 14-16 days. Typically, the crystals were about 0.05-0.50 mm in length, with a hexagonal cross-section of about 0.01-0.12 mm (Supplementary Fig. 1c) . Data collection. Initially, diffraction data sets to about 3.3 Å resolution were collected at the A-1 station of the Cornell High Energy Synchrotron Source (CHESS). The crystal was flash-cooled in a stream of liquid nitrogen with about 40% glycerol as the cryoprotectant, and maintained at about 100 K during data collection. Additionally, two data sets, each to 4.2 Å resolution, were measured at the CHESS F-2 station by tuning the beam to the peak and the inflection point of the iron absorption edge (inflection (1.7433 Å ): total 31,833, unique 9,814, completion 97%, I/sI highest 4.1, R merge 0.159; remote (1.7284 Å ): total 32,671, unique 9,903, completion 98%, I/sI highest 4.6, R merge 0.126). Finally, a 2.9-Å diffraction data set used for solution and refinement of the structure was gathered at cryogenic temperature at beamline 19-ID-D (0.979 Å ) of the Advanced Photon Source, Argonne National Laboratory. The data were recorded on an ADSC Q315 CCD detector and processed with the HKL3000 software package 33 . The space group was P3 2 21 and the unit cell parameters were a 5 b 5 140.2 Å , c 5 119.3 Å , a 5 b 5 90u, c 5 120u. There was one aromatase molecule in the asymmetric unit, with a solvent content of about 79%. A total of 184,295 diffraction intensities were measured, yielding 30,371 unique reflections. The diffraction data were 99.4% complete to 2.90 Å resolution with an overall intensity to sigma ratio of 31.1 and an R merge of 0.067. The intensity to sigma ratio was 2.8 in the highest-resolution shell. Supplementary Table 1 summarizes the diffraction data statistics.
Structure solution and refinement. The structure was solved by the molecular replacement method (at 3.3 Å ), coupled with Bijvoet difference Fourier synthesis with the Fe-absorption edge data sets (at 4.5 Å ). The latter helped in identifying the correct molecular replacement solution, at the same time confirming that there was one molecule in the asymmetric unit. Extensive rotation and translation function searches were conducted with a large number of P450 coordinates from the Protein Data Bank (PDB ID codes: 1PQ2, 1R90, 1TQN, 1Z10,  1W0E, 1Z11, 1ZO4, 1ZOA, 2F9Q, 2FDV, 2FDY, 2FDU, 2FDW, 2HI4, either a dual-CPU G5 or a Powerbook G4 with the Mac OS 10.4 operating system. The final model contained 452 amino-acid residues, a haem group, one androstenedione molecule, 35 solvent waters and 2 phosphate ions (3,767 total atoms). Models for 44 N-terminal and 7 C-terminal residues could not be built because of weakness of the their electron densities. Apart from these residues, the electron density for the rest of the molecule was mostly well defined, except for two short loop/turn regions. The fit between the experimental electron density of side chains and the corresponding sequence was excellent except for a few exposed charged amino acids, such as lysines. In the space of missing N-terminal residues, an isolated patch of weak electron density was identifiable and could be fitted to a four-turn helix. However, because of the lack of sidechain identities, the helix could not be modelled unequivocally. Additionally, electron densities for two detergent molecules were located near the Trp 67 side chain, the presumed transmembrane region of the enzyme, but were not included in the final refinement because of the possibility of multiple orientations of the sugar moiety or the alkyl chain. The final R factor for all reflections between 37.8 and 2.90 Å resolutions was 0.214, and the R-free value was 0.244. The r.m.s. deviations of bond lengths and angles from ideal values were 0.009 Å and 1.32u, respectively. The average isotropic thermal factor (B) for all atoms was 77.3 Å 2 , whereas the Wilson plot B-value was 94.5 Å 2 . Of 407 non-glycine and non-proline residues, there were two violations in the backbone torsion angle Ramachandran plot, all in weaker loop regions. Overall random coordinate errors were 0.33 Å (based on R-working), 0.26 Å (on R-free) and 0.19 Å (on maximum likelihood). A summary of all numbers from refinement is provided in Supplementary Table 1 . The overall structure of aromatase. The structure of aromatase consists of 12 major a-helices (A to L) and 10 b-strands (1 to 10) distributed into one major and three minor sheets, and follows the characteristic cytochrome P450 fold (Fig. 1a) . The major b-sheet is a mixed four-stranded sheet that begins near the N terminus (b1:83-88 and b2:93-97) but ends in two strands from the C-terminal half of the polypeptide chain (b3:373-376 and b6:393-396). The N-terminal residues 47-50 make one backbone hydrogen bond with b1 and add an extra b-strand-like element to this sheet in aromatase. Each of the three minor sheets consists of two antiparallel strands scattered over the polypeptide chain 
